Wall Street Financial Group’s AbbVie ABBV Stock Holding History

Wall Street Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$630K	Sell	2,504 -103	-4%	-$22.2K	0.34%	53
2026 Q1	$567K	Buy	+2,607	New	+$578K	0.34%	53
2025 Q4	–	Sell	-1,893	Closed	-$438K	–	97
2025 Q3	$438K	Sell	1,893 -18	-0.9%	-$3.67K	0.32%	49
2025 Q2	$355K	Buy	+1,911	New	+$355K	0.32%	42

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Wall Street Financial Group's ABBV Position: Q2 2026 in Review

Wall Street Financial Group reduced its AbbVie (ABBV) stake by 4% in Q2 2026, selling an estimated $22.2K and leaving 2,504 shares worth $630K. The position accounts for 0.34% of the portfolio, ranked #53.

Wall Street Financial Group first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wall Street Financial Group held 2,504 shares of AbbVie worth $630K as of Q2 2026.
Wall Street Financial Group sold 103 AbbVie shares in Q2 2026, an estimated $22.2K.
AbbVie made up 0.34% of Wall Street Financial Group's portfolio in Q2 2026, its #53 holding.
Wall Street Financial Group first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.